Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Melanoma × encorafenib × Clear all

Phase

Status

Sponsor Class

OTHER 15 INDUSTRY 10 NETWORK 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 1 Melanoma 1

Interventions

Interleukin-2 4 Nivolumab 3 Melphalan 3 pembrolizumab 2 tremelimumab 1 tislelizumab 1 fludarabine 1 encorafenib 1 binimetinib 1 apatinib 1 Tramadol 1 Surgical Procedures, Operative 1 Metastasectomy 1 Ipilimumab 1 Immunotherapy 1 Ibuprofen 1 FMT protocol 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05304546 2025-07-22

MK3475-C01

Sheba Medical Center

Phase 2 Completed

Melanoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡